Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231
Abstract Introduction Studies using different assays and technologies showed highly promising diagnostic value of plasma phosphorylated (P-)tau levels for Alzheimer’s disease (AD). We aimed to compare six P-tau Simoa assays, including three P-tau181 (Eli Lilly, ADx, Quanterix), one P-tau217 (Eli Lil...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9a80f98ef3db432c84a8599a0bf54390 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9a80f98ef3db432c84a8599a0bf54390 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9a80f98ef3db432c84a8599a0bf543902021-12-05T12:24:30ZClinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau23110.1186/s13195-021-00939-91758-9193https://doaj.org/article/9a80f98ef3db432c84a8599a0bf543902021-12-01T00:00:00Zhttps://doi.org/10.1186/s13195-021-00939-9https://doaj.org/toc/1758-9193Abstract Introduction Studies using different assays and technologies showed highly promising diagnostic value of plasma phosphorylated (P-)tau levels for Alzheimer’s disease (AD). We aimed to compare six P-tau Simoa assays, including three P-tau181 (Eli Lilly, ADx, Quanterix), one P-tau217 (Eli Lilly), and two P-tau231 (ADx, Gothenburg). Methods We studied the analytical (sensitivity, precision, parallelism, dilution linearity, and recovery) and clinical (40 AD dementia patients, age 66±8years, 50%F; 40 age- and sex-matched controls) performance of the assays. Results All assays showed robust analytical performance, and particularly P-tau217 Eli Lilly; P-tau231 Gothenburg and all P-tau181 assays showed robust clinical performance to differentiate AD from controls, with AUCs 0.936–0.995 (P-tau231 ADx: AUC = 0.719). Results obtained with all P-tau181 assays, P-tau217 Eli Lilly assay, and P-tau231 Gothenburg assay strongly correlated (Spearman’s rho > 0.86), while correlations with P-tau231 ADx results were moderate (rho < 0.65). Discussion P-tau isoforms can be measured robustly by several novel high-sensitive Simoa assays.Sherif BayoumyInge M. W. VerberkBen den DulkZulaiga HussainaliMarissa ZwanWiesje M. van der FlierNicholas J. AshtonHenrik ZetterbergKaj BlennowJeroen VanbrabantErik StoopsEugeen VanmechelenJeffrey L. DageCharlotte E. TeunissenBMCarticleAlzheimer’s diseaseBlood biomarkersP-tau181P-tau217P-tau231Phosphorylated tau proteinsNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENAlzheimer’s Research & Therapy, Vol 13, Iss 1, Pp 1-15 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Alzheimer’s disease Blood biomarkers P-tau181 P-tau217 P-tau231 Phosphorylated tau proteins Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
spellingShingle |
Alzheimer’s disease Blood biomarkers P-tau181 P-tau217 P-tau231 Phosphorylated tau proteins Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Sherif Bayoumy Inge M. W. Verberk Ben den Dulk Zulaiga Hussainali Marissa Zwan Wiesje M. van der Flier Nicholas J. Ashton Henrik Zetterberg Kaj Blennow Jeroen Vanbrabant Erik Stoops Eugeen Vanmechelen Jeffrey L. Dage Charlotte E. Teunissen Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231 |
description |
Abstract Introduction Studies using different assays and technologies showed highly promising diagnostic value of plasma phosphorylated (P-)tau levels for Alzheimer’s disease (AD). We aimed to compare six P-tau Simoa assays, including three P-tau181 (Eli Lilly, ADx, Quanterix), one P-tau217 (Eli Lilly), and two P-tau231 (ADx, Gothenburg). Methods We studied the analytical (sensitivity, precision, parallelism, dilution linearity, and recovery) and clinical (40 AD dementia patients, age 66±8years, 50%F; 40 age- and sex-matched controls) performance of the assays. Results All assays showed robust analytical performance, and particularly P-tau217 Eli Lilly; P-tau231 Gothenburg and all P-tau181 assays showed robust clinical performance to differentiate AD from controls, with AUCs 0.936–0.995 (P-tau231 ADx: AUC = 0.719). Results obtained with all P-tau181 assays, P-tau217 Eli Lilly assay, and P-tau231 Gothenburg assay strongly correlated (Spearman’s rho > 0.86), while correlations with P-tau231 ADx results were moderate (rho < 0.65). Discussion P-tau isoforms can be measured robustly by several novel high-sensitive Simoa assays. |
format |
article |
author |
Sherif Bayoumy Inge M. W. Verberk Ben den Dulk Zulaiga Hussainali Marissa Zwan Wiesje M. van der Flier Nicholas J. Ashton Henrik Zetterberg Kaj Blennow Jeroen Vanbrabant Erik Stoops Eugeen Vanmechelen Jeffrey L. Dage Charlotte E. Teunissen |
author_facet |
Sherif Bayoumy Inge M. W. Verberk Ben den Dulk Zulaiga Hussainali Marissa Zwan Wiesje M. van der Flier Nicholas J. Ashton Henrik Zetterberg Kaj Blennow Jeroen Vanbrabant Erik Stoops Eugeen Vanmechelen Jeffrey L. Dage Charlotte E. Teunissen |
author_sort |
Sherif Bayoumy |
title |
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231 |
title_short |
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231 |
title_full |
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231 |
title_fullStr |
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231 |
title_full_unstemmed |
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231 |
title_sort |
clinical and analytical comparison of six simoa assays for plasma p-tau isoforms p-tau181, p-tau217, and p-tau231 |
publisher |
BMC |
publishDate |
2021 |
url |
https://doaj.org/article/9a80f98ef3db432c84a8599a0bf54390 |
work_keys_str_mv |
AT sherifbayoumy clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT ingemwverberk clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT bendendulk clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT zulaigahussainali clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT marissazwan clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT wiesjemvanderflier clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT nicholasjashton clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT henrikzetterberg clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT kajblennow clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT jeroenvanbrabant clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT erikstoops clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT eugeenvanmechelen clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT jeffreyldage clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 AT charlotteeteunissen clinicalandanalyticalcomparisonofsixsimoaassaysforplasmaptauisoformsptau181ptau217andptau231 |
_version_ |
1718371973594087424 |